理解临床医生在早期脓毒症管理中如何个体化液体与血管升压药决策
该调查于2022年11月至2023年1月向美国重症医学会会员名册中11203名临床医生发放含10个脓毒症患者情景的问卷,550名(4.9%)完成至少1个情景。多因素逻辑回归显示,已接受的液体量是与后续补液和启动血管升压药决策最相关的因素:已接受1 L液体后调整后82.5%的受访者会追加液体、55.0%会启动血管升压药;已接受5 L后分别降至17.5%和升至92.7%。干性(容量不足)体征较湿性(容量过负荷)体征时更多受访者选择补液(66.9% vs 26.5%)。在无中心静脉通路的1023/1127个情景(90.8%)中,受访者愿意经外周静脉导管启动血管升压药。作者认为,未来个体化复苏研究必须考虑液体量,并应纳入具体工具帮助临床医生个体化复苏。
要点
- 已接受液体量是与后续补液和启动血管升压药决策最相关的因素,超过许多其他临床因素。
- 已接受1 L液体后,调整后82.5%(95%CI 80.2%-84.8%)的受访者会追加液体,55.0%(95%CI 51.9%-58.1%)会启动血管升压药。
- 已接受5 L液体后,调整后仅17.5%(95%CI 15.1%-19.9%)会追加液体,92.7%(95%CI 91.1%-94.3%)会启动血管升压药。
- 干性(容量不足)体征时调整后66.9%(95%CI 62.5%-71.2%)的受访者选择补液,湿性(容量过负荷)体征时为26.5%(95%CI 22.3%-30.6%)。
- 无中心静脉通路的1023/1127个情景(90.8%)中受访者愿意经外周静脉导管启动血管升压药。
适用人群与场景
- 美国重症医学会会员名册中的临床医生,2022年11月至2023年1月接受在线情景问卷调查
- 问卷包含10个脓毒症患者情景,情景中相关临床因素(如已接受液体量和容量状态)被随机化
处置流程与药物剂量
- 已接受1 L液体后,调整后82.5%(95%CI 80.2%-84.8%)的受访者选择追加液体,55.0%(95%CI 51.9%-58.1%)选择启动血管升压药
- 已接受5 L液体后,调整后17.5%(95%CI 15.1%-19.9%)的受访者选择追加液体,92.7%(95%CI 91.1%-94.3%)选择启动血管升压药
- 患者检查为干性(容量不足)体征时,调整后66.9%(95%CI 62.5%-71.2%)的受访者选择补液;湿性(容量过负荷)体征时为26.5%(95%CI 22.3%-30.6%)
- 无中心静脉通路时,1023/1127个情景(90.8%)中受访者愿意经外周静脉导管启动血管升压药
- 患者已接受外周去甲肾上腺素时,去甲肾上腺素剂量0.5 µg/kg/min较0.08 µg/kg/min更促使受访者置入中心静脉导管(调整后78.0%[95%CI 74.7%-81.2%] vs 25.2%[95%CI 21.8%-28.5%])
- 患者已接受外周去甲肾上腺素时,用药24小时较8小时更促使受访者置入中心静脉导管(调整后59.5%[95%CI 56.6%-62.5%] vs 47.1%[95%CI 44.0%-50.1%])
研究设计与关键结果
- 调查于2022年11月至2023年1月进行,数据分析于2023年2月至9月进行;11203名受邀临床医生中550名(4.9%;261名男性[47.5%]、192名女性[34.9%];173名执业>15年[31.5%])完成至少1个情景并纳入分析
- 受访者中多数为医生(337名[61.3%])和接受过重症医学培训者(369名[67.1%])
- 已接受液体量与复苏决策相关:1 L后调整后82.5%(95%CI 80.2%-84.8%)追加液体、55.0%(95%CI 51.9%-58.1%)启动血管升压药;5 L后调整后17.5%(95%CI 15.1%-19.9%)追加液体、92.7%(95%CI 91.1%-94.3%)启动血管升压药
- 干性vs湿性容量状态:调整后66.9%(95%CI 62.5%-71.2%)vs 26.5%(95%CI 22.3%-30.6%)的受访者选择补液
- 病史、呼吸状态、乳酸趋势和急性肾损伤与补液及血管升压药决策的关联较小
- 无中心静脉通路的1023/1127个情景(90.8%)中,受访者愿意经外周静脉导管启动血管升压药
- 已接受外周去甲肾上腺素时,剂量0.5 µg/kg/min较0.08 µg/kg/min更促使置入中心静脉导管(调整后78.0%[95%CI 74.7%-81.2%] vs 25.2%[95%CI 21.8%-28.5%]);24小时较8小时更促使置入中心静脉导管(调整后59.5%[95%CI 56.6%-62.5%] vs 47.1%[95%CI 44.0%-50.1%])
证据类型、等级与局限
- 证据类型:调查(在线情景问卷调查)
- 应答率4.9%(550/11203)
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,这些发现提示已接受的液体量是与后续补液和血管升压药决策相关的主要因素,超过许多其他临床因素
- 作者认为,外周血管升压药使用普遍
- 作者认为,未来旨在个体化复苏的研究必须考虑液体量,并应纳入具体工具帮助临床医生个体化复苏
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Recent sepsis trials suggest that fluid-liberal vs fluid-restrictive resuscitation has similar outcomes. These trials used generalized approaches to resuscitation, and little is known about how clinicians personalize fluid and vasopressor administration in practice.
OBJECTIVE: To understand how clinicians personalize decisions about resuscitation in practice.
DESIGN, SETTING, AND PARTICIPANTS: This survey study of US clinicians in the Society of Critical Care Medicine membership roster was conducted from November 2022 to January 2023. Surveys contained 10 vignettes of patients with sepsis where pertinent clinical factors (eg, fluid received and volume status) were randomized. Respondents selected the next steps in management. Data analysis was conducted from February to September 2023.
EXPOSURE: Online Qualtrics clinical vignette survey.
MAIN OUTCOMES AND MEASURES: Using multivariable logistic regression, the associations of clinical factors with decisions about fluid administration, vasopressor initiation, and vasopressor route were tested. Results are presented as adjusted proportions with 95% CIs.
RESULTS: Among 11 203 invited clinicians, 550 (4.9%; 261 men [47.5%] and 192 women [34.9%]; 173 with >15 years of practice [31.5%]) completed at least 1 vignette and were included. A majority were physicians (337 respondents [61.3%]) and critical care trained (369 respondents [67.1%]). Fluid volume already received by a patient was associated with resuscitation decisions. After 1 L of fluid, an adjusted 82.5% (95% CI, 80.2%-84.8%) of respondents prescribed additional fluid and an adjusted 55.0% (95% CI, 51.9%-58.1%) initiated vasopressors. After 5 L of fluid, an adjusted 17.5% (95% CI, 15.1%-19.9%) of respondents prescribed more fluid while an adjusted 92.7% (95% CI, 91.1%-94.3%) initiated vasopressors. More respondents prescribed fluid when the patient examination found dry vs wet (ie, overloaded) volume status (adjusted proportion, 66.9% [95% CI, 62.5%-71.2%] vs adjusted proportion, 26.5% [95% CI, 22.3%-30.6%]). Medical history, respiratory status, lactate trend, and acute kidney injury had small associations with fluid and vasopressor decisions. In 1023 of 1127 vignettes (90.8%) where the patient did not have central access, respondents were willing to start vasopressors through a peripheral intravenous catheter. In cases where patients were already receiving peripheral norepinephrine, respondents were more likely to place a central line at higher norepinephrine doses of 0.5 µg/kg/min (adjusted proportion, 78.0%; 95% CI, 74.7%-81.2%) vs 0.08 µg/kg/min (adjusted proportion, 25.2%; 95% CI, 21.8%-28.5%) and after 24 hours (adjusted proportion, 59.5%; 95% CI, 56.6%-62.5%) vs 8 hours (adjusted proportion, 47.1%; 95% CI, 44.0%-50.1%).
CONCLUSIONS AND RELEVANCE: These findings suggest that fluid volume received is the predominant factor associated with ongoing fluid and vasopressor decisions, outweighing many other clinical factors. Peripheral vasopressor use is common. Future studies aimed at personalizing resuscitation must account for fluid volumes and should incorporate specific tools to help clinicians personalize resuscitation.
参考来源
- Munroe ES, Weinstein J, Gershengorn HB, et al. Understanding How Clinicians Personalize Fluid and Vasopressor Decisions in Early Sepsis Management. JAMA Netw Open. 2024. PMID: 38639934. doi:10.1001/jamanetworkopen.2024.7480
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。